Literature DB >> 28855291

Effect of M-current modulation on mammalian vestibular responses to transient head motion.

Choongheon Lee1, J Chris Holt2, Timothy A Jones3.   

Abstract

The precise role and mechanisms underlying efferent modulation of peripheral vestibular afferent function are not well understood in mammals. Clarifying the details of efferent action may lead to new strategies for clinical management of debilitating disturbances in vestibular and balance function. Recent evidence in turtle indicates that efferent modulation of M-currents is likely one mechanism for modifying afferent discharge. M-currents depend in part on KCNQ potassium conductances (Kv7), which can be adjusted through efferent activation of M1, M3, and/or M5 muscarinic acetylcholine receptors (mAChRs). How KCNQ channels and altered M-currents affect vestibular afferent function in vivo is unclear, and whether such a mechanism operates in mammals is unknown. In this study we used the KCNQ antagonist XE991 and the KCNQ activator retigabine in anesthetized mice to evaluate the effects of M-current modulation on peripheral vestibular responses to transient head motion. At low doses of XE991, responses were modestly enhanced, becoming larger in amplitude and shorter in latency. Higher doses of XE991 produced transient response enhancement, followed by steady-state suppression where latencies and thresholds increased and amplitudes decreased. Retigabine produced opposite effects. Auditory function was also impacted, based on results of companion auditory brain stem response testing. We propose that closure of KCNQ channels transforms vestibular afferent behavior by suppressing responses to transient high-frequency stimuli while simultaneously enhancing responses to sustained low-frequency stimulation. Our results clearly demonstrate that KCNQ channels are critical for normal mammalian vestibular function and suggest that efferent action may utilize these mechanisms to modulate the dynamic characteristics and gain of vestibular afferent responses.NEW & NOTEWORTHY The role of calyceal KCNQ channels and associated M-current in normal mammalian vestibular function is unknown. Our results show that calyceal KCNQ channels are critical for normal vestibular function in the intact mammal. The findings provide evidence that efferent modulation of M-currents may act normally to differentially adjust the sensitivity of vestibular neurons to transient and tonic stimulation and that such mechanisms may be targeted to achieve effective clinical management of vestibular disorders.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  KCNQ channels; M-current; VsEP; XE991; calyx; mammal; retigabine; vestibular afferent

Mesh:

Substances:

Year:  2017        PMID: 28855291      PMCID: PMC5712666          DOI: 10.1152/jn.00384.2017

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  65 in total

1.  Far-field acoustic response: origins in the cat.

Authors:  J S Buchwald; C Huang
Journal:  Science       Date:  1975-08-01       Impact factor: 47.728

2.  On the high frequency transfer of mechanical stimuli from the surface of the head to the macular neuroepithelium of the mouse.

Authors:  Timothy A Jones; Choongheon Lee; G Christopher Gaines; J W Wally Grant
Journal:  J Assoc Res Otolaryngol       Date:  2015-02-04

Review 3.  Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells.

Authors:  P Wangemann
Journal:  Hear Res       Date:  1995-10       Impact factor: 3.208

4.  Differential effects of ouabain and ethacrynic acid on the labyrinthine potentials.

Authors:  P M Sellick; B M Johnstone
Journal:  Pflugers Arch       Date:  1974       Impact factor: 3.657

5.  KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.

Authors:  T Kharkovets; J P Hardelin; S Safieddine; M Schweizer; A El-Amraoui; C Petit; T J Jentsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ.

Authors:  Richard J Goodyear; Sherri M Jones; Louise Sharifi; Andy Forge; Guy P Richardson
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

7.  Tuning and timing in mammalian type I hair cells and calyceal synapses.

Authors:  Jocelyn E Songer; Ruth Anne Eatock
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

8.  A null mutation of mouse Kcna10 causes significant vestibular and mild hearing dysfunction.

Authors:  Sue I Lee; Travis Conrad; Sherri M Jones; Ayala Lagziel; Matthew F Starost; Inna A Belyantseva; Thomas B Friedman; Robert J Morell
Journal:  Hear Res       Date:  2013-03-22       Impact factor: 3.208

9.  Phospholipase C-mediated inhibition of the M-potassium current by muscarinic-receptor activation in the vestibular primary-afferent neurons of the rat.

Authors:  Cristina Pérez; Rosario Vega; Enrique Soto
Journal:  Neurosci Lett       Date:  2009-11-06       Impact factor: 3.046

10.  Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models.

Authors:  Guillermo Spitzmaul; Leonardo Tolosa; Beerend H J Winkelman; Matthias Heidenreich; Maarten A Frens; Christian Chabbert; Chris I de Zeeuw; Thomas J Jentsch
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

View more
  11 in total

1.  Efferent Inputs Are Required for Normal Function of Vestibular Nerve Afferents.

Authors:  Vishal Raghu; Richard Salvi; Soroush G Sadeghi
Journal:  J Neurosci       Date:  2019-07-08       Impact factor: 6.167

2.  Enhanced Activation of HCN Channels Reduces Excitability and Spike-Timing Regularity in Maturing Vestibular Afferent Neurons.

Authors:  Christopher M Ventura; Radha Kalluri
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

Review 3.  A review of efferent cholinergic synaptic transmission in the vestibular periphery and its functional implications.

Authors:  L A Poppi; J C Holt; R Lim; A M Brichta
Journal:  J Neurophysiol       Date:  2019-12-04       Impact factor: 2.714

4.  A novel intracochlear injection method for rapid drug delivery to vestibular end organs.

Authors:  Vishal Raghu; Yugandhar Ramakrishna; Robert F Burkard; Soroush G Sadeghi
Journal:  J Neurosci Methods       Date:  2020-05-04       Impact factor: 2.390

5.  Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.

Authors:  Jennifer Kersigo; Lintao Gu; Linjing Xu; Ning Pan; Sarath Vijayakuma; Timothy Jones; Seiji B Shibata; Bernd Fritzsch; Marlan R Hansen
Journal:  Laryngoscope       Date:  2020-05-21       Impact factor: 3.325

6.  Cholinergic Modulation of Membrane Properties of Calyx Terminals in the Vestibular Periphery.

Authors:  Yugandhar Ramakrishna; Marco Manca; Elisabeth Glowatzki; Soroush G Sadeghi
Journal:  Neuroscience       Date:  2020-11-13       Impact factor: 3.590

7.  Activation of GABAB receptors results in excitatory modulation of calyx terminals in rat semicircular canal cristae.

Authors:  Yugandhar Ramakrishna; Soroush G Sadeghi
Journal:  J Neurophysiol       Date:  2020-08-20       Impact factor: 2.714

8.  Effects of Several Therapeutic Agents on Mammalian Vestibular Function: Meclizine, Diazepam, and JNJ7777120.

Authors:  Choongheon Lee; Timothy A Jones
Journal:  J Assoc Res Otolaryngol       Date:  2021-05-19

Review 9.  Neuropharmacological Targets for Drug Action in Vestibular Sensory Pathways.

Authors:  Choongheon Lee; Timothy A Jones
Journal:  J Audiol Otol       Date:  2017-09-19

10.  Retinoic acid degradation shapes zonal development of vestibular organs and sensitivity to transient linear accelerations.

Authors:  Kazuya Ono; James Keller; Omar López Ramírez; Antonia González Garrido; Omid A Zobeiri; Hui Ho Vanessa Chang; Sarath Vijayakumar; Andrianna Ayiotis; Gregg Duester; Charles C Della Santina; Sherri M Jones; Kathleen E Cullen; Ruth Anne Eatock; Doris K Wu
Journal:  Nat Commun       Date:  2020-01-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.